Tirzepatide 10 mg/0 — Class II drug recall D-0771-2023
Ongoing recall by Revive Rx LLC dba Revive Rx Pharmacy, reported 2023-05-31, distributed nationwide. Sub-potent Drug
| Recall number | D-0771-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Revive Rx LLC dba Revive Rx Pharmacy, Houston, TX, United States |
| Recall initiated | 2023-05-11 |
| Classified | 2023-05-25 |
| Reported by FDA | 2023-05-31 |
| Distributed | Nationwide (US) |
| Quantity | 45 vials |
| Reason classes | potency |
| NDC | 99000-9278-64 |
| Lot numbers | 1643397 |
| Expiration dates | 2023-10-16 |
Product
Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug Product By: Revive Rx, 3831 Golf Dr A, Houston, TX 77018, NDC: 99000-9278-64.
Reason for recall
Sub-potent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0771-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.